Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evaluation of Dermal Acceptability and Comedogenic and Acnegenic Potential of a Cosmetic Product
Sponsor: Brainfarma Industria Química e Farmacêutica S/A
Summary
This is a single-center, single-blind clinical study designed to evaluate the dermatological safety of a cosmetic product and to demonstrate the absence of comedogenic and acnegenic potential. A total of 33 female participants, aged 18 to 60 years, with oily and acne-prone skin will be enrolled. Participants will use the investigational product for 28 days under normal conditions of use. Dermatological safety, skin tolerability, and the absence of comedogenic and acnegenic effects will be assessed throughout the study period by clinical evaluations conducted according to the study protocol.
Official title: Clinical Evaluation of Dermal Acceptability and the Comedogenic and Acnegenic Potential of a Cosmetic Product
Key Details
Gender
FEMALE
Age Range
18 Years - 45 Years
Study Type
INTERVENTIONAL
Enrollment
33
Start Date
2026-07-20
Completion Date
2026-09-17
Last Updated
2026-08-17
Healthy Volunteers
Yes
Conditions
Interventions
Blancy Pro
Blancy Pro is a cosmetic product intended for daily use in individuals with oily and acne-prone skin. Participants will use the product for 28 days under normal conditions of use. Dermatological safety and the absence of comedogenic and acnegenic potential will be evaluated through clinical assessments.
Locations (1)
Grupo Medcin
Osasco, São Paulo, Brazil